Optimising the quality of multidisciplinary team meetings: A narrative review

Tran, Thanh-Hai; Boer, Jasper de; Gyorki, David E.; Krishnasamy, Meinir

doi:10.1002/cam4.4432

Cited by 8 publications

(20 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…3 The purpose of MDT meetings is to provide opportunities for health professionals with differing expertise to meet on a regular basis with the aim of generating treatment recommendations on the basis of best evidence while taking into consideration patient preference. 4 It has been demonstrated that MDT decisions lead to revisions of cancer diagnoses and treatment plans in new cancer cases, better adherence to evidence-based guidelines, improved consideration for inclusion in clinical trials, and more accurate staging and treatment selections resulting in increased survival rates. 1,3,5 MDTs may improve patient satisfaction and patient trust.…”

Section: Introductionmentioning

confidence: 99%

“…1 The ability to implement clinical decisions and the effective care coordination by the multiteam affects quality of MDT working. 4,9-13…”

Section: Introductionmentioning

confidence: 99%

“…6,7 Barriers to MDTs include poor attendance, inadequate patient data, lack of technical support, unskilled leadership, and underprovision of administrative support. 4,8 Health professional roles and responsibilities, inadequate communication between specialists and primary care, hierarchical boundaries, and unequal participation in decision making are also issues to MDTs works. 1 The ability to implement clinical decisions and the effective care coordination by the multiteam affects quality of MDT working.…”

Section: Introductionmentioning

confidence: 99%

“…1 The ability to implement clinical decisions and the effective care coordination by the multiteam affects quality of MDT working. 4,[9][10][11][12][13] In this context, risk management can be of considerable importance in pursuing the MDT goals because even a lowrisk event could have serious consequences for patients, staff, costs, or hospital reputation. 14,15 This study aims to highlight sources of harm that could negatively affect decision making or affect the planning process of the lung MDT at the National Cancer Institute in Naples, by identifying existing or potential risks, their impact, and likelihood of damage occurrence and defining the appropriate mitigation strategies and priorities according to the international risk management standards (ISO 31000-2018).…”

Section: Introductionmentioning

confidence: 99%

“…Medical Oncology, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale," Napoli, Italy 2 Thoracic Surgery, Istituto Nazionale Tumori, "Fondazione G. Pascale," IRCCS, Napoli, Italy 3 Radiotherapy, Istituto Nazionale Tumori "Fondazione G. Pascale," IRCCS, Naples, Italy4 Pathology, Istituto Nazionale Tumori, "Fondazione G. Pascale," IRCCS, Napoli, Italy5 Radiology, Istituto Nazionale Tumori, "Fondazione G. Pascale," IRCCS, Napoli, Italy6 Clinical Trials Unit, Istituto Nazionale Tumori, "Fondazione G. Pascale," IRCCS, Napoli, Italy7 Scientific Directorate, Istituto Nazionale Tumori "Fondazione G. Pascale," IRCCS, Napoli, Italy8 Rehabilitative Medicine Unit, Istituto Nazionale Tumori "Fondazione G.…”

unclassified

See 4 more Smart Citations

Risk Management Activities in a Lung Cancer Multidisciplinary Team at a Comprehensive Cancer Center: Results of a Prospective Analysis

Morabito

Mercadante

Muto

et al. 2023

JCO Oncology Practice

View full text Add to dashboard Cite

PURPOSE: The objective of the study was to highlight sources of harm that could negatively affect the lung cancer multidisciplinary team (MDT) activities to reduce the level of risk of each factor. METHODS: A modified Delphi approach was used by a board of multi–health care professionals of the lung cancer MDT to identify the main processes, subprocesses, and risk factors of the multidisciplinary pathway of patients with lung cancer. A semiquantitative matrix was built with a five-point scale for probability of harm (likelihood) and severity of harm (consequences) according to the international risk management standards (ISO 31000-2018). The risk level was calculated by multiplying likelihood × consequences. Mitigation strategies have been identified and applied by the MDT to reduce risks to acceptable levels. RESULTS: Three main processes (outpatient specialist visit, MDT discussion, and MDT program implementation), eight related subprocesses, and 16 risk factors were identified. Four risk factors (25%) were related to outpatient specialist visit, seven (43.75%) to case discussion, and five (31.25%) to program implementation. Overall, two risk factors were assigned a low-risk level (12.5%), 11 a moderate-risk level (68.75%), one (6.25%) a high-risk level, and two (12.5%) a very high-risk level. After the implementation of mitigation measures, the new semiquantitative risk analysis showed a reduction in almost all hazardous situations: two risk factors (12.5%) were given a very low level, six (37.5%) a low level, seven (43.75%) a moderate level, and one (6.25%) a very high level. CONCLUSION: An interdisciplinary risk assessment analysis is applicable to MDT activities by using an ad hoc risk matrix: if the hazard is identified and monitored, the risk could be reduced and managed in a short time.

show abstract

Section: Introductionmentioning

confidence: 99%

“…1 The ability to implement clinical decisions and the effective care coordination by the multiteam affects quality of MDT working. 4,9-13…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

unclassified

See 3 more Smart Citations

Risk Management Activities in a Lung Cancer Multidisciplinary Team at a Comprehensive Cancer Center: Results of a Prospective Analysis

Morabito

Mercadante

Muto

et al. 2023

JCO Oncology Practice

View full text Add to dashboard Cite

show abstract

Optimising the quality of multidisciplinary team meetings: A narrative review

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand

Rajadevan,

Flinkier,

Saunders

et al. 2024

Aust NZ J Obst Gynaeco

View full text Add to dashboard Cite

BackgroundMucinous ovarian carcinoma (MOC) is a rare ovarian cancer with limited evidence to support clinical care.AimsWe undertook a clinician survey to better understand current practice in treating MOC in Australia and New Zealand, and to determine any features associated with variation in care. In addition, we aimed to understand future research priorities.MethodsA RedCap survey was distributed to clinician members of the Australia New Zealand Gynaecological Oncology Group (ANZGOG). Questions included respondent demographics, three case studies and future research priorities. Clinicians were asked questions specific to their speciality.ResultsRespondents (n = 47) were commonly experienced gynae‐oncology specialists, most often surgical (38%) or medical (30%) oncologists. There was good consensus for surgical approaches for stage I disease; however, variation in practice was noted for advanced or recurrent MOC. Variation was also observed for medical oncologists; in early‐stage disease there was no clear consensus on whether to offer chemotherapy, or which regimen to recommend. For advanced and recurrent disease a wide range of chemotherapy options was considered, with a trend away from an ovarian‐type toward gastrointestinal (GI)‐type regimens in advanced MOC. This practice was reflected in future research priorities, with ‘Is a GI chemotherapy regimen better than an ovarian regimen?’ the most highly ranked option, followed by ‘Should stage 1C patients receive chemotherapy?’ConclusionsAlthough the number of respondents limited the analyses, it was clear that chemotherapy selection was a key point of divergence for medical oncologists. Future research is needed to establish well‐evidenced guidelines for clinical care of MOC.

show abstract

Optimising the quality of multidisciplinary team meetings: A narrative review

Abstract: This is an open access article under the terms of the Creat ive Commo ns Attri bution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Cited by 8 publications

References 36 publications

Risk Management Activities in a Lung Cancer Multidisciplinary Team at a Comprehensive Cancer Center: Results of a Prospective Analysis

Risk Management Activities in a Lung Cancer Multidisciplinary Team at a Comprehensive Cancer Center: Results of a Prospective Analysis

Optimising the quality of multidisciplinary team meetings: A narrative review

Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand

Contact Info

Product

Resources

About